Myomo (NYSEAMERICAN:MYO) Director Purchases $28,760.55 in Stock

Myomo, Inc. (NYSEAMERICAN:MYO) Director Thomas Kirk bought 31,605 shares of the company’s stock in a transaction dated Friday, May 15th. The stock was bought at an average cost of $0.91 per share, with a total value of $28,760.55. Following the completion of the transaction, the director owned 585,462 shares in the company, valued at approximately $532,770.42. This trade represents a 5.71% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Myomo Trading Up 4.2%

NYSEAMERICAN:MYO opened at $0.91 on Thursday. The company has a 50-day moving average price of $0.77 and a 200-day moving average price of $0.84. Myomo, Inc. has a 12 month low of $0.61 and a 12 month high of $3.39. The company has a current ratio of 2.73, a quick ratio of 2.36 and a debt-to-equity ratio of 1.21. The stock has a market cap of $35.35 million, a price-to-earnings ratio of -2.54 and a beta of 1.39.

Wall Street Analysts Forecast Growth

Separately, Craig Hallum reaffirmed a “buy” rating on shares of Myomo in a research report on Tuesday, March 10th. Four research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $7.67.

Institutional Trading of Myomo

A number of large investors have recently made changes to their positions in the stock. Rosalind Advisors Inc. grew its stake in shares of Myomo by 1.3% in the fourth quarter. Rosalind Advisors Inc. now owns 3,839,772 shares of the company’s stock worth $3,494,000 after acquiring an additional 48,984 shares during the period. Jefferies Financial Group Inc. bought a new stake in shares of Myomo in the fourth quarter worth approximately $641,000. Geode Capital Management LLC grew its stake in shares of Myomo by 160.8% in the second quarter. Geode Capital Management LLC now owns 669,281 shares of the company’s stock worth $1,446,000 after acquiring an additional 412,631 shares during the period. AQR Capital Management LLC grew its position in Myomo by 47.8% during the fourth quarter. AQR Capital Management LLC now owns 434,376 shares of the company’s stock valued at $395,000 after buying an additional 140,427 shares during the period. Finally, State Street Corp grew its position in Myomo by 5.1% during the fourth quarter. State Street Corp now owns 399,853 shares of the company’s stock valued at $364,000 after buying an additional 19,563 shares during the period. 44.99% of the stock is currently owned by institutional investors.

Myomo Company Profile

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.